研究成果: |
主持科研项目: 1. 国家自然科学基金青年科学基金项目,2023-01 至 2025-12, 结题, 主持。 2. 吉林省自然科学基金,面上项目(不含医学科学领域),2024-2026, 在研,主持。 3. 第七批吉林省青年科技人才托举工程,2023-09至2025-12,结题,主持。 代表性论文: 1. Sun, R.; Jiao, Y.; Chen, J.; Pang, X.; Xue, B.; Yao, J.; Li, G.; Zhang, Y.; Yang, J.;* Teng, L.* Neutrophil-Mediated Delivery Platforms for Synergistic Chemo-Immunotherapy of Non-Small-Cell Lung Cancer Therapy. Nano Lett. 2025, 25, 14229-14236. 2. Jiao, Y.; Chen, J.; Lei, H.; Hu, S.; Yu, Y.; Yang, J.; Chen, Y.; Yang, J.;* Teng, L.* Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis. Nano Lett. 2026, 26, 2381-2388. 3. Li, X.; Shen, M.; Yang, J.;* Liu, L.;* Yang, Y. W.* Pillararene‐Based Stimuli‐Responsive Supramolecular Delivery Systems for Cancer Therapy. Adv. Mater. 2024, 36, 2313317. 4. Han, S.; Zhang, X.; Li, Z.; Cui, G.; Xue, B.; Yu, Y.; Guo, J.; Zhang, H.; Yang, J.;* Teng, L.* A ginsenoside G-Rg3 PEGylated long-circulating liposome for hyperglycemia and insulin resistance therapy in streptozotocin-induced type 2 diabetes mice. Eur. J. Pharm. Biopharm. 2024, 201, 114350. 5. Yang, J.; Lou, X.-Y.; Dai, D.; Shi, J.;* Yang, Y.-W.* Desymmetrized pillar[8]arenes: High-yield synthesis, functionalization, and host-guest chemistry. Chin. Chem. Lett. 2025, 36, 109818. 6. Yang, J.; Dai, D.; Zhang, X.; Teng, L.; Ma, L.; Yang, Y.-W.* Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy. Theranostics 2023, 13, 295-323. 7. Li, X.; Yang, J.;* Yang, Y.-W.* Recent advances of stimuli-responsive viologen-based nanocomposites. Mater. Chem. Front. 2023, 7, 1463-1481. 8. Yang, J.; Dai, D.; Cai, Z.; Liu, Y.-Q.; Qin, J.-C.; Wang, Y.; Yang, Y.-W.* MOF-Based Multi-Stimuli-Responsive Supramolecular Nanoplatform Equipped with Macrocycle Nanovalves for Plant Growth Regulation. Acta Biomater. 2021, 134, 664–673. 9. Yang, J.; Yang, Y.-W.* Metal–Organic Frameworks for Biomedical Applications. Small 2020, 16, 1906846. 10. Yang, J.; Yang, Y.-W.* Metal-Organic Framework-Based Cancer Theranostic Nanoplatforms. View 2020, 1, e20. |